Fas signaling is involved in the control of hair follicle response to chemotherapy

32Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Chemotherapeutic agents induce p53-dependent apoptosis in the hair follicle (HF) resulting in hair loss, a common side effect of cancer therapy. Here, we show that Fas as a p53 target plays important role in the HF response to cyclophosphamide. Specifically, we demonstrate that Fas is up-regulated in HF keratinocytes after cyclophosphamide treatment, Fas ligand-neutralizing antibody partially inhibits HF response to cyclophosphamide in wild-type mice, and Fas knockout mice show significant retardation of cyclophosphamide-induced HF involution associated with reduced Fas-associated death domain and caspase-8 expression. These data raise a possibility to explore blockade of Fas signaling as a part of complex local therapy for inhibiting keratinocyte apoptosis and hair loss induced by chemotherapy.

Cite

CITATION STYLE

APA

Sharov, A. A., Siebenhaar, F., Sharova, T. Y., Botchkareva, N. V., Gilchrest, B. A., & Botchkarev, V. A. (2004). Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Research, 64(17), 6266–6270. https://doi.org/10.1158/0008-5472.CAN-04-1367

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free